Expert NetworkExpert InterviewLLY

Slingshot members are talking to an expert! The topic is:

Evaluating Eli Lilly's Orforglipron and its Phase 3 ATTAIN-1 Clinical Trial Results in Obesity Management

Executed on:Aug 19, 2025 5:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: CentraCare Health
  • Board Certified Endocrinologist at CentraCare Health 
  • Manages 400 patients annually for weight loss and obesity.
  • Practicing in endocrinology for over 20 years with a specific interest in obesity and type 2 diabetes research and treatments

Interview Goal

On this call we will be discussing the positive topline results from Eli Lilly’s Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight with a weight-related medical problem (without diabetes).

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.